| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 07/22/1993 | WO1993014225A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
| 07/22/1993 | WO1993014220A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | WO1993014209A1 Vaccines based on streptokinase |
| 07/22/1993 | WO1993014208A2 Hepatitis e virus vaccine and method |
| 07/22/1993 | WO1993014206A2 Synthetic peptides for a rubella vaccine |
| 07/22/1993 | WO1993014202A1 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 07/22/1993 | WO1993014201A1 Dna encoding a human 5-ht1f receptor and uses thereof |
| 07/22/1993 | WO1993014194A1 Recombinant swinepox virus |
| 07/22/1993 | WO1993014190A1 Feline leukemia virus vaccines |
| 07/22/1993 | WO1993014125A1 Novel lymphocytic antigen, corresponding antibody and applications thereof |
| 07/22/1993 | WO1993014123A1 A novel human kunitz-type protease inhibitor and variants thereof |
| 07/22/1993 | WO1993014122A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014121A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | WO1993014119A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | WO1993014117A1 Peptides of the casein macropeptide, antibodies directed against said peptides, and applications |
| 07/22/1993 | WO1993014116A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | WO1993014111A1 Novel compound ustiloxin a or b, or derivative thereof |
| 07/22/1993 | WO1993014098A1 Antigen recognized by patients with antibody associated lambert-eaton myasthenic syndrome (lems), dna encoding same and uses thereof |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993013784A1 Platelet transfusion |
| 07/22/1993 | WO1993009235A3 Ubiquitin-specific proteases |
| 07/22/1993 | CA2127883A1 A method for amplifying and detecting a target nucleic acid sequence of hiv-1 |
| 07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | CA2127473A1 Peptides of the casein macropeptide, antibodies directed against said peptides and applications |
| 07/22/1993 | CA2127466A1 Feline leukemia virus vaccines |
| 07/22/1993 | CA2127368A1 Platelet transfusion |
| 07/22/1993 | CA2127249A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2127248A1 Human kunitz-type protease inhibitor variants |
| 07/22/1993 | CA2127247A1 A novel human kunitz-type protease inhibitor and variants thereof |
| 07/22/1993 | CA2127246A1 A human kunitz-type protease inhibitor variant |
| 07/22/1993 | CA2125701A1 Hepatitis e virus vaccine and method |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/21/1993 | EP0551671A1 Treponema hyodysenteriae vaccine |
| 07/21/1993 | EP0551506A1 System for protein expression and secretion especially in corynebacteria |
| 07/21/1993 | EP0551501A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 07/21/1993 | EP0551446A1 A onco-fetal gene, gene product and uses therefor |
| 07/21/1993 | EP0551440A1 Design of bioactive peptides based on immunoglobulin structure |
| 07/21/1993 | EP0551438A1 Surface expression libraries of randomized peptides |
| 07/21/1993 | EP0551400A1 Method for treating inflammation using anti-idiotypic antibodies |
| 07/21/1993 | EP0551329A1 Aprotinin analogues |
| 07/21/1993 | EP0551325A1 Method of testing for salmonella |
| 07/21/1993 | EP0551324A1 Salmonella polynucleotide sequence. |
| 07/21/1993 | EP0551304A1 Fungicidally active compounds |
| 07/21/1993 | EP0551301A1 Cd53 cell surface antigen and use thereof |
| 07/21/1993 | EP0536215A4 Neurofibromatosis gene |
| 07/21/1993 | EP0342188B1 Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor |
| 07/21/1993 | EP0245481B1 Yeast strains |
| 07/21/1993 | EP0242359B1 A cloning vehicle for cloning a large fragment of dna and a vaccine comprising 987p fimbrial protein |
| 07/21/1993 | EP0179887B1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 07/21/1993 | CN1074483A Cultivation and maintenance of thymocyte agamic cell lines |
| 07/20/1993 | US5229496 Amplified expression of recombinant DNA products |
| 07/20/1993 | US5229495 Transforming growth factor |
| 07/20/1993 | US5229362 Antibiotic A10255 complex and factors, and process and production therefor |
| 07/20/1993 | US5229293 Recombinant baculovirus |
| 07/20/1993 | US5229275 Transforming lymphocytes using 8-mercaptoguanosine and interleukin adjuvants |
| 07/20/1993 | US5229272 Catalytic antibody components |
| 07/20/1993 | CA1320460C Anti-human gastric cancer monoclonal antibody |
| 07/20/1993 | CA1320459C Anti-human pulmonary carcinoma monoclonal antibody |
| 07/15/1993 | WO1993014408A1 Myotonin receptors and screening methods |
| 07/15/1993 | CA2105167A1 Myotonin receptors and screening methods |
| 07/14/1993 | EP0551107A2 Method for a beta-galactosidase catalyzed transglycosilation with non-physiological glycosyl-donors |
| 07/14/1993 | EP0550955A2 Chimeric antibody against human GMP-140 |
| 07/14/1993 | EP0550946A2 Genes encoding porcine zona pellucida protein PZP-4, expression thereof and contraceptive vaccines comprising expressed (poly)peptides |
| 07/14/1993 | EP0550691A1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides. |
| 07/14/1993 | EP0550661A1 Gro genes, proteins, and uses thereof |
| 07/14/1993 | EP0550629A1 Metal ion mediated receptor binding of polypeptide hormones |
| 07/14/1993 | EP0550626A1 Method of improving the yield of heterologous proteins produced by streptomyces lividans |
| 07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
| 07/14/1993 | EP0550519A1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 07/14/1993 | EP0550506A1 Novel chemotactic factor |
| 07/14/1993 | EP0550485A1 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/14/1993 | EP0550450A1 Use of crosslinked crystals as a novel form of enzyme immobilization |
| 07/14/1993 | CN1074243A Fusion Protein Interleukin 2/6, its preparation and application |
| 07/14/1993 | CA2087143A1 Cenp-b epitope |
| 07/13/1993 | US5227471 Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma |
| 07/13/1993 | US5227294 Method of producing surfactin with the use of mutant of bacillus subtilis |
| 07/13/1993 | US5227160 Contraceptives, treatment of infertility |
| 07/13/1993 | CA1320163C Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 07/13/1993 | CA1320162C Method for stabilizing heterologous protein expression and vectors for use therein |
| 07/13/1993 | CA1320160C Monoclonal antibodies against ifn-omega, processes for preparing them and their use in the purification and detection of ifn-omega |
| 07/10/1993 | CA2086972A1 Process for .beta.-galactosidase-catalyzed transglycosidation with unphysiological glycosyl donors |
| 07/08/1993 | WO1993013222A1 Dna structure-specific recognition protein and uses therefor |
| 07/08/1993 | WO1993013211A1 Expression and purification of recombinant soluble tissue factor |
| 07/08/1993 | WO1993013210A1 Icams immunoglobulin constant region soluble fusion proteins |
| 07/08/1993 | WO1993013209A1 Expression signal-peptide-free staphylokinases |
| 07/08/1993 | WO1993013206A1 Stem cell inhibiting proteins |
| 07/08/1993 | WO1993013205A1 Neuroblastoma-associated regulator gene |
| 07/08/1993 | WO1993013203A1 Hybrid cells producing an antigen characteristic of the hepatitis b virus |
| 07/08/1993 | WO1993013202A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 07/08/1993 | WO1993013196A2 Method for increasing recombinant protein production |
| 07/08/1993 | WO1993013134A1 Monoclonal antibody to hiv-2 and uses thereof |
| 07/08/1993 | WO1993013133A1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
| 07/08/1993 | WO1993013130A1 Somatostatin receptors |
| 07/08/1993 | WO1993013125A1 Protein production |
| 07/08/1993 | WO1993013114A1 COMPOSITIONS AND METHODS FOR MODULATING β-AMYLOID |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993012816A1 Monoclonal antibodies against type i phospholipase a2, used as a therapeutic agent to reduce inflammation |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |